457 related articles for article (PubMed ID: 27509054)
21. Interleukin-1 beta in oral submucous fibrosis, verrucous hyperplasia and squamous cell carcinoma tissues.
Tsai CC; Chen CC; Lin CC; Chen CH; Lin TS; Shieh TY
Kaohsiung J Med Sci; 1999 Sep; 15(9):513-9. PubMed ID: 10561975
[TBL] [Abstract][Full Text] [Related]
22. Enhanced interferon signaling pathway in oral cancer revealed by quantitative proteome analysis of microdissected specimens using 16O/18O labeling and integrated two-dimensional LC-ESI-MALDI tandem MS.
Chi LM; Lee CW; Chang KP; Hao SP; Lee HM; Liang Y; Hsueh C; Yu CJ; Lee IN; Chang YJ; Lee SY; Yeh YM; Chang YS; Chien KY; Yu JS
Mol Cell Proteomics; 2009 Jul; 8(7):1453-74. PubMed ID: 19297561
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformation.
Angadi PV; Krishnapillai R
Head Neck Pathol; 2012 Sep; 6(3):314-21. PubMed ID: 22392409
[TBL] [Abstract][Full Text] [Related]
24. Connecting cyto-nano-architectural attributes and epithelial molecular expression in oral submucous fibrosis progression to cancer.
Bag S; Pal M; Chaudhary A; Das RK; Paul RR; Sengupta S; Chatterjee J
J Clin Pathol; 2015 Aug; 68(8):605-13. PubMed ID: 26038241
[TBL] [Abstract][Full Text] [Related]
25. The phosphorylation of survivin Thr34 by p34cdc2 in carcinogenesis of oral submucous fibrosis.
Zhou S; Li L; Jian X; Ou X; Jiang H; Yao Z; Xu C; Peng J
Oncol Rep; 2008 Nov; 20(5):1085-91. PubMed ID: 18949405
[TBL] [Abstract][Full Text] [Related]
26. Elevated Lin28B expression is correlated with lymph node metastasis in oral squamous cell carcinomas.
Lin WT; Shieh TM; Yang LC; Wang TY; Chou MY; Yu CC
J Oral Pathol Med; 2015 Nov; 44(10):823-30. PubMed ID: 25726847
[TBL] [Abstract][Full Text] [Related]
27. Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis.
Moutasim KA; Jenei V; Sapienza K; Marsh D; Weinreb PH; Violette SM; Lewis MP; Marshall JF; Fortune F; Tilakaratne WM; Hart IR; Thomas GJ
J Pathol; 2011 Feb; 223(3):366-77. PubMed ID: 21171082
[TBL] [Abstract][Full Text] [Related]
28. An Evaluation of Clinical and Histopathological Aspects of Patients with Oral Submucous Fibrosis in the Background of Oral Squamous Cell Carcinoma.
Siriwardena BSMS; Jayawardena KLTD; Senarath NH; Tilakaratne WM
Biomed Res Int; 2018; 2018():4154165. PubMed ID: 30402477
[TBL] [Abstract][Full Text] [Related]
29. Expression of hTERT in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma - an Immunohistochemical Analysis.
Raju K L; Haragannavar VC; Patil S; Rao RS; Nagaraj T; Augustine D; Venkatesiah SS; Nambiar S
Pathol Oncol Res; 2020 Jul; 26(3):1573-1582. PubMed ID: 31489575
[TBL] [Abstract][Full Text] [Related]
30. Low LINC02147 expression promotes the malignant progression of oral submucous fibrosis.
Chen J; Li W; Liu B; Xie X
BMC Oral Health; 2022 Jul; 22(1):316. PubMed ID: 35906577
[TBL] [Abstract][Full Text] [Related]
31. IRF4 as a novel target involved in malignant transformation of oral submucous fibrosis into oral squamous cell carcinoma.
Meng L; Jiang Y; You J; Zhao P; Liu W; Zhao N; Yu Z; Ma J
Sci Rep; 2023 Feb; 13(1):2775. PubMed ID: 36797470
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of IFI27 inhibits cell proliferation and invasion in oral squamous cell carcinoma.
Wang H; Qiu X; Lin S; Chen X; Wang T; Liao T
World J Surg Oncol; 2018 Mar; 16(1):64. PubMed ID: 29580248
[TBL] [Abstract][Full Text] [Related]
33. Change and pathological significance of glycogen content in oral squamous cell carcinoma and oral submucous fibrosis.
Nie H; Hu X; Xiong H; Zeng L; Chen W; Su T
Tissue Cell; 2024 Apr; 87():102337. PubMed ID: 38430849
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic model of saliva peptide finger print analysis of oral squamous cell carcinoma patients using weak cation exchange magnetic beads.
Jiang WP; Wang Z; Xu LX; Peng X; Chen F
Biosci Rep; 2015 May; 35(3):. PubMed ID: 26182373
[TBL] [Abstract][Full Text] [Related]
35. [Molecules of G(2)/M phase and the phosphorylation of survivin in the carcinogenesis of oral submucosal fibrosis].
Zhou SH; Li LL; Jian XC; Wang Y; Chen XQ; Gao X
Zhonghua Kou Qiang Yi Xue Za Zhi; 2008 Dec; 43(12):709-12. PubMed ID: 19134343
[TBL] [Abstract][Full Text] [Related]
36. High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas.
Kidani K; Osaki M; Tamura T; Yamaga K; Shomori K; Ryoke K; Ito H
Oral Oncol; 2009 Jan; 45(1):39-46. PubMed ID: 18619895
[TBL] [Abstract][Full Text] [Related]
37. Low-dose arecoline regulates distinct core signaling pathways in oral submucous fibrosis and oral squamous cell carcinoma.
Li Z; Fu Y; Hu Y; Zhu Y; Hu L; Shi C; Zhang Y; Zhang J; Zhou S
BMC Oral Health; 2023 Mar; 23(1):171. PubMed ID: 36966276
[TBL] [Abstract][Full Text] [Related]
38. Acylglycerol kinase promotes the proliferation and cell cycle progression of oral squamous cell carcinoma.
Liu G; Ren X; Gao C; Zhang W
Mol Med Rep; 2015 Aug; 12(2):2225-30. PubMed ID: 25872568
[TBL] [Abstract][Full Text] [Related]
39. Salivary zinc finger protein 510 peptide as a novel biomarker for detection of oral squamous cell carcinoma in early stages.
Jou YJ; Lin CD; Lai CH; Tang CH; Huang SH; Tsai MH; Chen SY; Kao JY; Lin CW
Clin Chim Acta; 2011 Jul; 412(15-16):1357-65. PubMed ID: 21497587
[TBL] [Abstract][Full Text] [Related]
40. Proteomic Profiling of Paired Interstitial Fluids Reveals Dysregulated Pathways and Salivary NID1 as a Biomarker of Oral Cavity Squamous Cell Carcinoma.
Hsu CW; Chang KP; Huang Y; Liu HP; Hsueh PC; Gu PW; Yen WC; Wu CC
Mol Cell Proteomics; 2019 Oct; 18(10):1939-1949. PubMed ID: 31315917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
